https://www.selleckchem.com/products/sc144.html
a highlight the value of integrating CMR and clinical parameters for risk stratification in this population. Published data suggest worse outcomes in acute coronary syndrome (ACS) patients and concurrent coronavirus disease 2019 (COVID-19) infection. Mechanisms remain unclear. The purpose of this study was to report the demographics, angiographic findings, and in-hospital outcomes of COVID-19 ACS patients and compare these with pre-COVID-19 cohorts. From March 1, 2020 to July 31, 2020, data from 55 international centers were entered into
Like
Comment
Share
